IgA driven autoimmune hemolytic anemia: a monocentric Italian report and literature review. (PubMed, Blood Transfus) - Sep 15, 2026 - "IgA-mediated AIHA is a rare, heterogeneous subtype characterized by frequent dual antibody positivity, suboptimal corticosteroid response, and substantial risks of relapse and complications, requiring careful monitoring and individualized management. These findings highlight the need for improved recognition of IgA-mediated disease and prospective studies to define optimal second-line therapies and outcomes in affected patients."
Journal • Anemia • Autoimmune Hemolytic Anemia • Cardiovascular • Fatigue • Hematological Disorders • Immunology • Infectious Disease • Pulmonary Disease
|
|
Bruno Fattizzo; Elisa Tarasconi; Giacinto L Pedone; Marta Bortolotti; Nicoletta Revelli; Wilma Barcellini
|